Education
About Us
Working with TipRanks
Follow Us
Neuroscientific Biopharmaceuticals Ltd. (AU:NSB)
:NSB
RESEARCH TOOLSreports
NSB Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.03 - AU$0.19
Previous CloseN/A
Volume70.60K
Average Volume (3M)520.66K
Market Cap
AU$58.20M
Enterprise ValueAU$45.39M
Total Cash (Recent Filing)AU$4.49M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)21.3
Beta0.38
Next Earnings
Aug 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding332,575,700
10 Day Avg. Volume607,941
30 Day Avg. Volume520,660
Financial Highlights & Ratios
PEG Ratio0.07
Price to Book (P/B)4.57
Price to Sales (P/S)0.00
P/FCF Ratio44.56
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Neuroscientific Biopharmaceuticals Ltd. News
PremiumCompany Announcements
NeuroScientific Biopharmaceuticals Director Increases Shareholding
PremiumCompany Announcements
NeuroScientific Biopharmaceuticals Acquires Breakthrough Stem Cell Technology
PremiumCompany Announcements
NeuroScientific Biopharmaceuticals Announces Director Change
PremiumCompany Announcements
NeuroScientific Biopharmaceuticals Issues New Securities Under Section 708A
PremiumCompany Announcements
Neuroscientific Biopharmaceuticals Issues New Equity Securities
PremiumCompany Announcements
Neuroscientific Biopharmaceuticals Announces Issuance of Performance SharesOptions Prices
Currently, No data available
---
Ownership Overview
1.50%
Insiders
―
Mutual Funds
― Other Institutional Investors
98.50% Public Companies and
Individual Investors
NSB FAQ
What was Neuroscientific Biopharmaceuticals Ltd.’s price range in the past 12 months?
Neuroscientific Biopharmaceuticals Ltd. lowest share price was AU$0.03 and its highest was AU$0.18 in the past 12 months.
What is Neuroscientific Biopharmaceuticals Ltd.’s market cap?
Neuroscientific Biopharmaceuticals Ltd.’s market cap is AU$58.20M.
When is Neuroscientific Biopharmaceuticals Ltd.’s upcoming earnings report date?
Neuroscientific Biopharmaceuticals Ltd.’s upcoming earnings report date is Aug 28, 2025 which is in 37 days.
How were Neuroscientific Biopharmaceuticals Ltd.’s earnings last quarter?
Currently, no data Available
Is Neuroscientific Biopharmaceuticals Ltd. overvalued?
According to Wall Street analysts Neuroscientific Biopharmaceuticals Ltd.’s price is currently Overvalued.
Does Neuroscientific Biopharmaceuticals Ltd. pay dividends?
Neuroscientific Biopharmaceuticals Ltd. does not currently pay dividends.
What is Neuroscientific Biopharmaceuticals Ltd.’s EPS estimate?
Neuroscientific Biopharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Neuroscientific Biopharmaceuticals Ltd. have?
Neuroscientific Biopharmaceuticals Ltd. has 332,575,700 shares outstanding.
What happened to Neuroscientific Biopharmaceuticals Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Neuroscientific Biopharmaceuticals Ltd.?
Currently, no hedge funds are holding shares in AU:NSB
Neuroscientific Biopharmaceuticals Ltd. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:NSB Sentiment 70%
Sector Average 72%
Sector Average 72%
Insider Transactions
Bought Shares
Worth AU$92.8K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
337.50%
12-Months-Change
Fundamentals
Return on Equity
26.99%
Trailing 12-Months
Asset Growth
27.50%
Trailing 12-Months
Company Description
Neuroscientific Biopharmaceuticals Ltd.
Neuroscientific Biopharmaceuticals Ltd. (NSB) is a biotechnology company specializing in the development of novel peptide-based pharmaceutical products targeting neurodegenerative conditions. The company operates within the pharmaceutical and biotechnology sectors, focusing on creating innovative therapies for diseases such as Alzheimer's, Parkinson's, and Multiple Sclerosis. NSB's core product portfolio includes patented compounds aimed at enhancing neuron survival and regeneration.